Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.47 - $4.61 $40,241 - $53,462
11,597 New
11,597 $47,000
Q2 2020

Aug 10, 2020

SELL
$9.66 - $12.02 $131,627 - $163,784
-13,626 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$7.5 - $16.8 $293,415 - $657,249
-39,122 Reduced 74.17%
13,626 $141,000
Q4 2019

Feb 04, 2020

BUY
$12.38 - $17.47 $653,020 - $921,507
52,748 New
52,748 $866,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $286M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.